Griffiths Richard Ian bought SLN
August 3, 2025 · Form 4 insider transaction
Griffiths Richard Ian bought 20,000 shares of Silence Therapeutics plc, a transaction worth N/A. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 194 days after the transaction.
Footnotes
Each American Depositary Share ("ADS") is immediately convertible into three ordinary shares for no consideration and has no expiration date.; The securities were sold by Ora Capital Limited ("OCL") and purchased by Mr. Griffiths personally, essentially internal transfers with no change in total beneficial holding. Mr Griffiths is a director and the controlling shareholder of OCL. Mr. Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein.